3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
2
Not yet recruiting
1
Enrolling by invitation
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
69
Neoplasms
53
Colorectal Neoplasms
49
Carcinoma, Non-Small-Cell Lung
42
Prostatic Neoplasms
41
Lung Neoplasms
36
Pancreatic Neoplasms
27
Leukemia, Myeloid, Acute
23
Multiple Myeloma
22
Recurrence
18
Carcinoma, Hepatocellular
18
Uterine Cervical Neoplasms
16
Ovarian Neoplasms
15
Head and Neck Neoplasms
15
Neoplasm Metastasis
14
Melanoma
14
Triple Negative Breast Neoplasms
13
Squamous Cell Carcinoma of Head and Neck
13
Stomach Neoplasms
12
Glioblastoma
12
Brain Neoplasms
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Endometrial Neoplasms
11
Rectal Neoplasms
10
Carcinoma, Renal Cell
10
Advanced Solid Tumors
10
Lymphoma, B-Cell
9
Disease
9
Colonic Neoplasms
9
Esophageal Neoplasms
8
Interventions
tocilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Cytokine Release Syndrome
×
30 days
×
Clear all
NCT07609940
2026-05-27
POPLIN
Regeneron Pharmaceuticals
Phase 4
Not yet recruiting
30 enrolled